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Background: Pulmonary function is not fully reversible in asthma in children and may continue into adult life. This
study was to determine the association between asthma and reduced pulmonary function in adults and the
modification by sex and atopic status.
Methods: A cross-sectional study of 1492 adults aged 18 years or over was conducted in a rural community. Atopy,
height, weight, waist circumference (WC) and pulmonary function were measured. Participants with ever asthma
were those who reported by questionnaire a history of asthma diagnosed by a physician during lifetime.
Participants who had former (only) asthma were those who reported having physician-diagnosed asthma more
than 12 months ago. Participants who had recent asthma were those who reported having asthma during the last
12 months.
Results: Men had higher values of forced vital capacity (FVC) and forced expiratory volume in one second (FEV1)
compared with women, but FEV1/FVC ratio showed no significant difference between sexes. Atopic status was not
related to pulmonary function and the average values of the pulmonary function testing variables were almost the
same for non-atopic and atopic individuals. Individuals with ever, recent or former asthma had significant lower
values of FEV1 and FEV1/FVC ratio than those who reported having no asthma, and the associations tended to be
stronger in men than in women. The interaction between atopy and asthma was not statistically significant.
Conclusions: Adults who reported having recent asthma or former asthma had reduced pulmonary function,
which was significantly modified by sex but not by atopic status.
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Asthma is an inflammatory airway disease and airway
function may not be completely reversible in those with
asthma. Studies have revealed reduced pulmonary func-
tion in individuals with clinically stable asthma [1] or a
history of asthma [2,3] in children and young adults.
Chronic airway inflammation may result in long-term
pulmonary function reduction in asthma patients [4,5]
including thickening of the airway wall and the develop-
ment of incompletely reversible airway narrowing, airway
hyperresponsiveness, and reduced airway distensibility [6].
The anomalies may occur early in disease pathogenesis
[7,8], and continues into adult life [9], however data from* Correspondence: ychen@uottawa.ca
1Department of Epidemiology and Community Medicine, Faculty of
Medicine, University of Ottawa, 451, Smyth Road, Ottawa, Ontario K1H 8 M5,
Canada
Full list of author information is available at the end of the article
© 2012 Chen et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the oradult populations are scarce. Atopy may [10] or may not
[1,11] influence the association between asthma and pul-
monary function. In this study we examined the associ-
ation between asthma and pulmonary function and the
effect modification of sex and atopy in a general popula-
tion of adults to clarify these issues.Methods
Study population
In the present analysis we used data from a cross-
sectional study conducted in the town of Humboldt, Sas-
katchewan, in 2003. A total of 2057 adults participated in
the study, 71% of the target population of all town resi-
dents aged 18 to 79 years. The study was approved by the
University of Saskatchewan research ethics board and
consent was obtained from each participant. The details
have been described in previous reports [12-14].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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All the participants completed a self-administrated ques-
tionnaire, and provided information including demo-
graphic factors, education, occupation, income, smoking
habits, coffee and alcohol consumption, respiratory
symptoms and illnesses. Participants with ever asthma
were those who responded positively to one or both of
the following question: 1) “During the past 12 months,
has a doctor ever said you had asthma?”; and 2) “Before
the past 12 months, has a doctor ever said you had
asthma?”. Participants with former (only) asthma were
those who responded “no” to the first question but “yes”
the second question. Participants with recent asthma
were those who responded “yes” to the first question.
Individuals who reported smoking every day or almost
everyday, and had smoked at least 20 packs during their
lifetime, were defined as current smokers. People who
were regular smokers but at the time of the survey, had
quit for at least 6 months, were considered as former
smokers. Otherwise, subjects were defined as non-
smokers. Perceived level of physical activities was also
recorded. Physical activity in spare time was measured by




Subjects without asthma (n = 674) (n = 818)
Age (years) 51.2 ± 15.2* 50.5 ± 15.7
Weight(kg) 90.2 ± 15.9 74.4 ± 16.3
Height (m) 175.5 ± 6.3 162.5 ± 6.3
BMI†(kg/m2) 29.2 ± 4.8 28.2 ± 6.0
WC†(cm) 100.5 ± 12.1 87.8 ± 14.0
Packyears 9.5 ± 14.5 5.8 ± 15.8
FVC†(L) 4.77 ± 0.99 3.43 ± 0.76
FEV1
†(L) 3.80 ± 0.86 2.78 ± 0.65
FEV1/FVC(%) 79.6 ± 7.5 80.9 ± 6.0
Subjects with ever asthma (n = 33) (n = 89)
Age (years) 51.2 ± 16.4 47.5 ± 16.4
Weight(kg) 86.5 ± 14.9 78.3 ± 15.5
Height (m) 175.6 ± 7.5 162.6 ± 6.1
BMI(kg/m2) 28.1 ± 4.6 29.7 ± 6.3
WC(cm) 99.3 ± 12.1 92.5 ± 14.5
Packyears 9.5 ± 16.6 7.1 ± 22.7
FVC(L) 4.58 ± 1.06 3.41 ± 0.88
FEV1(L) 3.46 ± 1.07 2.74 ± 0.82
FEV1/FVC(%) 74.8 ± 9.93 79.6 ± 8.1
*Mean± standard deviation.
†BMI, body mass index; FVC, forced vital capacity; FEV1, forced expired volume in onyour age now spend their spare time, would you say you
are: more physically active, equally physically active or less
physically active?” We use the same definitions in previous
reports [12-14].Clinical measurements
During a clinical visit, lung function, height, weight and
waist circumference (WC) were measured. Weight was
measured to the nearest 0.1 kg. Height and WC were
measured in centimetres. Height was measured using a
fixed tape measure with participants standing shoeless
on a hard surface. Waist circumference was measured
between the lowest rib and the iliac crest, horizontally
through the narrowest part of the torso [15]. BMI was
calculated as weight (kg)/height2 (m2).
Skin prick testing included 4 allergens: D pteronyssinus,
mixed grasses # (Western Allergy, Vancouver, CA), Fel d,
Alternaria tenius, as well as positive (histamine) and nega-
tive (saline) controls (Omega Laboratories and Hollister-
Stier, Mississauga, CA). Adults were considered atopic if
they had a raised wheal greater than or equal to 3 mm
compared to the saline control on skin prick testing [16].moking by sex and atopy in subjects with and without
Atopy
No Yes Total
(n = 1060) (n = 432) (n = 1492)
51.7 ± 15.2 48.7 ± 15.8 50.8 ± 15.5
80.7 ± 17.7 83.6 ± 18.2 81.5 ± 17.9
168.1 ± 8.9 169.1 ± 9.2 168.4 ± 9.0
28.4 ± 5.5 29.2 ± 5.7 28.7 ± 5.5
92.9 ± 14.6 95.1 ± 14.3 93.6 ± 14.6
7.9 ± 16.7 6.4 ± 11.3 7.5 ± 15.4
3.99 ± 1.09 4.14 ± 1.09 4.04 ± 1.10
3.20 ± 0.91 3.33 ± 0.90 3.24 ± 0.91
80.2 ± 6.7 80.6 ± 6.7 80.3 ± 6.7
(n = 68) (n = 54) (n = 122)
52.9 ± 16.7 42.9 ± 14.4 48.5 ± 16.4
80.4 ± 16.6 80.6 ± 14.8 80.5 ± 15.7
165.4 ± 9.2 166.9 ± 8.1 166.1 ± 8.7
29.4 ± 5.9 29.1 ± 5.9 29.3 ± 5.9
95.5 ± 15.2 92.9 ± 12.7 94.3 ± 14.2
7.3 ± 15.0 8.3 ± 27.1 7.7 ± 21.1
3.49 ± 1.00 4.02 ± 1.06 3.72 ± 1.06
2.73 ± 0.88 3.20 ± 0.97 2.94 ± 0.95
77.7 ± 9.7 79.0 ± 7.7 78.3 ± 0.89
e second; WC, waist circumference.
Table 2 Adjusted means and 95% confidence intervals of




Mean 95% CI Mean 95% CI Mean 95% CI
Sex
Men 4.39 4.34-4.45 3.54 3.49-3.59 80.6 79.9-81.2
Women 3.72 3.67-3.76 2.97 2.93-3.01 79.9 79.3-80.4
P value <0.001 <0.001 0.158
Atopy
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poration. St. Paul, MN 55127, 1992) was used for pulmon-
ary function testing. Two machines were calibrated using
a standard syringe every morning during the study period.
Each subject was tested based on the American Thoracic
Society criteria defined in the 1987 Standardization of
Spirometry [17]. Forced vital capacity (FVC), forced ex-
piratory volume in one second (FEV1) and FEV1/FVC (%)
were included in this analysis. Values were corrected to
body temperature and pressure saturated with water
vapour (BTPS).No 4.01 3.98-4.04 3.22 3.19-3.24 80.2 79.8-80.6
Yes 4.02 3.97-4.07 3.22 3.18-3.27 80.1 79.6-80.7
P value 0.668 0.776 0.924
Ever asthma
No 4.02 3.99-4.05 3.23 3.20-3.26 80.4 80.0-80.7
Yes 3.92 3.82-4.02 3.07 2.98-3.16 77.8 76.7-79.0
P value 0.050 0.001 <0.001
*Multivariate analysis of variance; models included sex, age, height, weight,
waist circumference, smoking, atopy and asthma.
†FVC, forced vital capacity; FEV1, forced expired volume in one second; SE,
standard error; WC, waist circumference.Statistical analysis
We examined the associations of pulmonary function
with ever, recent and former asthma and their variations
between men and women and between atopic and non-
atopic individuals by using multivariate analysis of vari-
ance (MANOVA). FVC, FEV1 and FEV1/FVC(%) were
considered simultaneously, and sex, age, height, body
weight, WC and pack-years of smoking (one pack-year is
equal to 20 cigarettes smoked per day for a year) were
adjusted. Adjusted means and 95% confidence intervals
for pulmonary function testing variables were calculated
for subjects with and without asthma and their differ-
ences associated with sex and atopic status were deter-
mined and related interactions were tested. Associations
were considered to be statistically significant if p values
were less than 0.05 (two sides). All the analyses were
conducted by using SPSS version 11.5.Results
Of 2057 participants, 1492 (72.5%) provided all related
questionnaire information, had pulmonary function test-
ing and skin prick testing results and height, weight and
WC measures. Table 1 describes the distribution of an-
thropometric measures, pulmonary function testing vari-
ables and pack-years of smoking according to the status
of ever asthma stratified by sex and atopic status.
In multivariate analysis, we first examined the inde-
pendent associations of FVC and FEV1 and FEV1/FVC
ratio with ever asthma, sex and atopy. Age, height,
weight, WC and pack-years of smoking were important
predictors for FVC and FEV1 and/or FEV1/FVC ratio
and were included in the regression models (Table 2).
Body mass index was no longer significant predictor and
was excluded from the models. Interactions for these
variables with asthma status were not statistically signifi-
cant at the alpha level of 0.05. Ever asthma was signifi-
cantly associated with reduced FEV1 and FEV1/FVC
ratio, while atopy showed no impact on the pulmonary
function testing variables. Women had lower mean
values of FVC and FEV1 compared with men, but aver-
age FEV1/FVC ratio was almost the same.Similar results were revealed when former asthma and
recent asthma were considered separately. Significantly
lower values of FEV1 and FEV1/FVC ratio were observed
in those with former asthma than those with no asthma
and in those with recent asthma than those without re-
cent asthma (Figure 1).
The association between asthma and reduced FEV1
was more pronounced in men than in women and in
non-atopic than atopic individuals. Table 3 shows that
on average people with ever asthma had a reduction of
0.33 L of FEV1 compared to non-asthmatic persons in
men (p<0.05), and the corresponding reduction was
only 0.09 L for women (p> 0.05). The interaction be-
tween asthma and sex was statistically significant. Ever
asthma was associated with a reduction of 0.20 L of
FEV1 in people with no atopy (p<0.05) and with only
0.10 L in atopic people (p> 0.05), but the interaction be-
tween ever asthma and atopy was not statistically signifi-
cant. Similarly, the association between ever asthma and
FEV1/FVC ratio was statistically significant in men and
non-atopic people, but not in women and atopic people,
while the interaction between asthma and atopy did not
reach statistical significance. We did not detect other
important effect modifiers for the association between
asthma status and pulmonary function testing variables.
Discussion
Our data demonstrated that adults with asthma had
reduced airway function indicated by FEV1 and FEV1/
FVC ratio in adults. This reduced airway function was
observed not only in adults with recent asthma but also
Figure 1 Adjusted means of FEV1 and FEV1/FVC in subjects with former asthma (n= 58) and recent asthma (n= 64) compared with
those with no asthma history.
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sistent with earlier observations among children and
young adults. Nakadate and Kagawa [3] investigated 441
primary school children and found reduced lung func-
tion with a history of asthma even if they had been in re-
mission for several years. Yang et al. [1] found reduced
lung function in 242 children with clinically stable
asthma compared with 100 non-asthmatic controls.Table 3 Adjusted means and 95% confidence intervals of
lung function testing variables related to ever asthma







Mean 95% CI Mean 95% CI Mean 95% CI
Sex
Men No 4.41 4.35-4.46 3.56 3.51-3.61 80.9 80.2-81.5
Yes 4.21 4.02-4.41 3.23 3.05-3.40 76.2 74.0-78.5
Women No 3.72 3.67-3.77 2.97 2.93-3.02 80.0 79.4-80.5





No No 4.02 3.99-4.05 3.23 3.20-3.26 80.4 80.0-80.8
Yes 3.88 3.75-4.02 3.03 2.91-3.15 77.5 75.9-79.1
Yes No 4.03 3.97-4.08 3.23 3.18-3.28 80.3 79.7-80.9




*Multivariate analysis of variance; models included sex age, height, weight,
waist circumference, smoking, atopy and asthma as well as sex x asthma or
atopy x asthma interaction term.
†FVC, forced vital capacity; FEV1, forced expired volume in one second; SE,
standard error; WC, waist circumference.Mosfeldt Laursen et al. [2] studied 77 children or young
adults aged 12–24 years with former asthma, current
asthma or no asthma and demonstrated that former
asthmatics with no current respiratory symptoms had
obstructive airflow limitation and increased bronchial
responsiveness.
Our data suggest that in adults with recent or former
asthma, pulmonary function was not fully reversible.
The damage to airway function is likely due to patho-
logical modification of the bronchial airway structures or
airway remodeling. Although the mechanisms are not
fully understood, there is an expansion of the airway wall
vascular compartment involving both enlargement of
existing vascular structures and the formation of new
vessels [6], and an increased smooth muscle mass and
airway narrowing [18]. Damage to the epithelium may
play an important role in the process, which can be
caused by exposures to pathogens, allergens, environ-
mental pollutants, cigarette smoke, and mechanical in-
juries [19]. Irreversible loss of pulmonary function in
asthma can begin in childhood and continue into adult
life [9]. In a cohort from birth to the age of 26 years Ras-
mussen et al. [9] found that asthma in childhood was
associated with a low postbronchodilator ratio of FEV1
to vital capacity at the age of 18 and 26 years, and with
an accelerated decline in pulmonary function and
decreased reversibility. Thus, asthma may cause some
permanent airway function damage. Irreversible airway
obstruction is related to poor prognosis in asthma [20].
In the present study, we found that sex was a signifi-
cant effect modifier for the association between asthma
and pulmonary function. The reduction in pulmonary
function due to recent or former asthma was more
marked in men than in women. A previous study
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associated with low postbronchodilator ratio of FEV1 to
vital capacity [9]. In animal studies, sex influences the
remodeling process in asthma [21,22], and possible rea-
sons need to be further explored. Reporting bias should
not be ignored for the observed sex difference if men
tended to under-report and/or women to over-report
asthma. In our study, women were more likely to have
asthma than men, and this has been observed in previ-
ous surveys in the same region and in Canada. A recent
report demonstrated that female sex was an independent
risk factor for the incidence of non-allergic asthma [23].
Non-allergic asthma was more likely to be under-
diagnosed but the diagnoses bias was similar for men
and women [23] The differences in asthma prevalence
and incidence need to be further explored.
Our data demonstrated that atopy had no notable im-
pact on pulmonary function. Some previous cross-
sectional and longitudinal studies have shown no signifi-
cant associations between atopy and FEV1 in adults
[24,25]. One study found that atopy alone was not
related to the FEV1, but in atopic patients the relation-
ship between bronchial hyperresponsiveness and FEV1
was stronger compared with nonatopic patients [26].
Other studies demonstrated that atopy was related to
lower lung function in young adults with asthma [27] or
independently of asthma [28]. Atopy seems not an inde-
pendent risk factor for pulmonary function in children
[1,29], although atopy was found to be associated with
low pulmonary function in children with asthma or
wheeze [30]. Our study showed that atopy did not sig-
nificantly modify the association between asthma and
pulmonary function and was not an important risk fac-
tor for pulmonary function in adults.
Among the study subjects, 27 reported using asthma
medication during the past 12 months. Self-reported
asthma medication use during the past 12 months did
not significantly predict pulmonary function or modified
the association between asthma and pulmonary function
testing variables. One limitation of the study is that
asthma diagnosis is solely based on self-reporting. The
current study did not have information on bronchial
hyperreactivity. If pulmonary function was fully revers-
ible in asthma and chronic obstructive pulmonary dis-
ease (COPD) was misdiagnosed as asthma, we would
have observed reduced pulmonary function in “asthma”
patients. Since COPD is common in elderly people but
rare in young adults, we analyzed the data stratified by
age. The association between self-reported asthma and
pulmonary function was similar in younger and older
age groups. In addition, self-reported former asthma,
which is not likely to be COPD, was significantly related
to low pulmonary function, suggesting possible informa-
tion bias is not an explanation for our findings. In thisstudy we used four most important allergens for our
skin prick test and 28% were positive. A larger panel of
allergens would increase the likelihood of atopy
detected, and there was a potential under-diagnosis of
atopy in our study.
Conclusions
There was reduced pulmonary function in adults with
ever, recent or former asthma and the association tended
to be stronger in men than in women, but similar in
those with and without atopy. There is a possibility that
airway remodeling in asthma results in reduced pulmon-
ary function and risk factors for irreversible airway ob-
struction need further investigation.
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